Meral Kayikcioglu/
Dec 3, 2025, 02:29
Meral Kayikcioglu: Successfully Completing FDA Inspections for Two Phase 3 Trials
Meral Kayikcioglu, Professor of Cardiology at Ege University and Director of the Lipid and Prevention Clinic, shared on LinkedIn:
“We successfully completed FDA inspections for two different Phase 3 RCTs (LIB-HoFH and HeFH)! This extremely challenging and prestigious inspection in pharmaceutical R&D processes also demonstrated our compliance with global standards.
To my knowledge, only 10 FDA inspections have been conducted in our country to date. Successfully passing one of these inspections is a source of great pride for both our team and our country. I thank all my teammates and stakeholders who contributed to this process.
We continue to work for stronger, more innovative, and more reliable science!”

Stay updated with Hemostasis Today.
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials